|
ALT levels (U/L)
|
Hypertensive n, (%)
|
Age-Sex-adjusted OR (95% CI)
|
Multivariable-adjusted OR (95% CI)*
|
|---|
|
Continuous variable
| | | |
|
ALT
|
887,509 (4.21)
|
1.01 (1.01,1.01)
|
1.01 (1.01,1.01)
|
|
Categorical variable
| | | |
|
Group I
| | | |
|
0–40
|
676,607 (3.63)
|
1
|
1
|
|
> 40
|
210,902 (8.56)
|
2.05 (2.04,2.07)
|
1.55 (1.54,1.56)
|
|
Group II
| | | |
|
0–20
|
308,328 (2.87)
|
1
|
1
|
|
20.01–40
|
368,279 (4.65)
|
1.35 (1.34,1.35)
|
1.22 (1.21,1.22)
|
|
40.01–60
|
112,137 (8.02)
|
2.21 (2.20,2.23)
|
1.67 (1.65,1.68)
|
|
60.01–80
|
47,326 (8.88)
|
2.54 (2.52,2.57)
|
1.78 (1.76,1.80)
|
|
> 80
|
51,439 (9.64)
|
2.90 (2.88,2.93)
|
1.92 (1.90,1.94)
|
|
Pfor trend†
| |
< 0.001
|
< 0.001
|
- ALT: alanine aminotransferase; OR: odds ratios; CI: confidence interval;
- *Adjusted for age, sex, ethnicity, area, education, body mass index, average salt consumption, history of diabetes, overall stress and hepatitis B surface antigen status
- †P for trend was calculated by setting categorized ALT levels as a continuous variable
